Few, if any, areas of medical therapeutics have witnessed such dramatic changes as those that have occurred in the therapy of rheumatoid arthritis (RA) during the past two decades. Improvements in ...

Objective Paraoxonase-1 (PON1) is a high-density lipoprotein (HDL)-associated enzyme, that has been implicated as a biomarker ...

In past decades, remission was seldom assessed as an outcome measure... An earlier randomized, placebo-controlled study of stoppage versus continuation of DMARD therapy in patients with ...